Genes of Oxidative Stress and Atherosclerotic Complications of Hypertension
Genes of Oxidative Stress and Atherosclerotic Complications of Hypertension
批准号:
7640744
负责人:
JAMES E. HIXSON
金额:
$37.65万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2013-05-31
关键词:
African AmericanAgeAlcohol consumptionAmericanArchitectureArterial DisorderAtherosclerosisBody SizeChinese PeopleClinicalCoronary ArteriosclerosisCoronary arteryDNADataDevelopmentDiseaseEarly identificationEpidemiologyEssential HypertensionFamily history ofFunctional disorderGenderGenesGeneticGenetic PolymorphismGenetic RiskGenetic VariationHispanicsHypertensionIndividualInflammationInjuryMeasuresModelingNetwork-basedNot Hispanic or LatinoOxidative StressOxidative Stress PathwayParticipantPathway interactionsPharmaceutical PreparationsPhysical ExaminationPlayPopulation HeterogeneityPredispositionProcessRaceResearchResearch Project GrantsResourcesRiskRisk FactorsRoleSamplingSingle Nucleotide PolymorphismSmokingTestingVariantWomancalcificationcohortcoronary artery calcificationdisorder riskgene environment interactiongene interactiongenetic epidemiologymenpublic health relevance
中文摘要
描述(由申请人提供):动脉粥样硬化是冠状动脉疾病(CAD)的主要原因,是美国男性和女性的最大杀手。氧化应激导致内皮功能障碍是高血压导致动脉粥样硬化过程的潜在因素。该项目题为“高血压的氧化应激和动脉粥样硬化并发症的基因”,旨在描述氧化应激途径基因变异在冠状动脉钙化(CAC)遗传结构中的作用,CAC是亚临床冠状动脉粥样硬化的一种衡量标准。该研究项目将使用基因网络方法来识别影响冠状动脉抵抗高血压损伤能力的基因。所有的DNA资源,CAD风险因素,体检数据和CAC措施已经从三个队列中提供给这个项目。将使用CAC评价遗传多态性、协变量、高血压和亚临床冠状动脉粥样硬化之间的假设关系的模型,CAC已在具有原发性高血压个人或家族史的个体中测量,来自罗切斯特的动脉病遗传流行病学网络(GENOA),MN fieldcenter和来自冠状动脉钙化流行病学(ECAC)研究的有高血压个人或家族史的个体,同样来自明尼苏达州的罗切斯特。将在多种族动脉粥样硬化研究(梅萨)的个体中寻求重复结果的普遍性。我们将使用这种基于氧化应激基因网络的方法超越单一多态性效应,并研究单基因、基因与基因的相互作用和基因与环境的相互作用如何联合收割机影响高血压或高血压风险增加的个体的CAC量。
公共卫生相关性
动脉粥样硬化是冠状动脉疾病(CAD)的主要原因,CAD是美国男性和女性的最大杀手。增加我们对遗传变异在不同人群亚临床冠状动脉粥样硬化中的作用的理解,有助于早期识别对临床疾病易感性增加的个体,开发新的,更有效的治疗方法,并为那些最有可能应答的人定制治疗方法。
英文摘要
DESCRIPTION (provided by applicant): Atherosclerosis is the major cause of coronary artery disease (CAD), the single largest killer of American men and women. Oxidative stress leading to endothelial dysfunction is an underlying factor whereby hypertension contributes to the atherosclerotic process. This project entitled "Genes of Oxidative Stress and Atherosclerotic Complications of Hypertension" proposes to characterize the role of oxidative stress pathway gene variation in the genetic architecture of coronary artery calcification (CAC), a measure of subclinical coronary atherosclerosis. This research project will use a gene network approach to identify genes that influence the ability of the coronary artery to resist injury due to hypertension. All DNA resources, CAD risk factors, physical examination data and CAC measures are already available to this project from three cohorts. Models of the hypothesized relationships between genetic polymorphisms, covariates, hypertension and subclinical coronary atherosclerosis will be evaluated using CAC, already measured on individuals with a personal or family history of essential hypertension from the Genetic Epidemiology Network of Arteriopathy (GENOA), Rochester, MN fieldcenter and on individuals with a personal or family history of hypertension from the Epidemiology of Coronary Artery Calcification (ECAC) study, also from Rochester, MN. The generalizability of findings which replicate will be sought in the individuals of the Multi-Ethnic Study of Atherosclerosis (MESA). We will use this oxidative stress gene network-based approach to move beyond single polymorphism effects and investigate how single-genes, gene-by-gene interactions and gene-by-environment interactions combine to influence CAC quantity in individuals with hypertension or at increased risk of hypertension.
PUBLIC HEALTH RELEVANCE
Atherosclerosis is the major cause of coronary artery disease (CAD), the single largest killer of American men and women. Increasing our understanding of the role of genetic variation in sub-clinical coronary atherosclerosis in diverse populations can contribute to the earlier identification of individuals with increased susceptibility to clinical disease, the development of new, more efficacious treatments, and tailoring of treatments to those most likely to respond.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next-Generation Medical Resequencing of Gout Disease Genes in the ARIC Cohort
-
批准号:7945359
-
项目类别:
-
资助金额:$144.89万
-
财政年份:2009
-
负责人:JAMES E. HIXSON
-
依托单位:
Next-Generation Medical Resequencing of Gout Disease Genes in the ARIC Cohort
-
批准号:7853113
-
项目类别:
-
资助金额:$131.77万
-
财政年份:2009
-
负责人:JAMES E. HIXSON
-
依托单位:
Genes of Oxidative Stress and Atherosclerotic Complications of Hypertension
-
批准号:8269611
-
项目类别:
-
资助金额:$37.8万
-
财政年份:2008
-
负责人:JAMES E. HIXSON
-
依托单位:
Genes of Oxidative Stress and Atherosclerotic Complications of Hypertension
-
批准号:8072700
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2008
-
负责人:JAMES E. HIXSON
-
依托单位:
Genes of Oxidative Stress and Atherosclerotic Complications of Hypertension
-
批准号:7845021
-
项目类别:
-
资助金额:$37.65万
-
财政年份:2008
-
负责人:JAMES E. HIXSON
-
依托单位:
GENOTYPING CORE
-
批准号:7707387
-
项目类别:
-
资助金额:$14.25万
-
财政年份:2008
-
负责人:JAMES E. HIXSON
-
依托单位:
GENCAC - MOLECULAR GENETICS LABORATORY
-
批准号:6786687
-
项目类别:
-
资助金额:$44.42万
-
财政年份:2001
-
负责人:JAMES E. HIXSON
-
依托单位:
GENCAC - MOLECULAR GENETICS LABORATORY
-
批准号:6527765
-
项目类别:
-
资助金额:$14.04万
-
财政年份:2001
-
负责人:JAMES E. HIXSON
-
依托单位:
MOLECULAR GENETICS OF ATHEROSCLEROSIS
-
批准号:6448206
-
项目类别:
-
资助金额:$49.81万
-
财政年份:2001
-
负责人:JAMES E. HIXSON
-
依托单位:
GENCAC - MOLECULAR GENETICS LABORATORY
-
批准号:6364648
-
项目类别:
-
资助金额:$11.86万
-
财政年份:2001
-
负责人:JAMES E. HIXSON
-
依托单位:
GENCAC - MOLECULAR GENETICS LABORATORY
-
批准号:6659084
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2001
-
负责人:JAMES E. HIXSON
-
依托单位:
MOLECULAR GENETICS OF ATHEROSCLEROSIS
-
批准号:6302227
-
项目类别:
-
资助金额:$34.71万
-
财政年份:2000
-
负责人:JAMES E. HIXSON
-
依托单位:
MOLECULAR GENETICS OF ATHEROSCLEROSIS
-
批准号:6110057
-
项目类别:
-
资助金额:$34.71万
-
财政年份:1999
-
负责人:JAMES E. HIXSON
-
依托单位:
MOLECULAR GENETICS OF ATHEROSCLEROSIS
-
批准号:6272893
-
项目类别:
-
资助金额:$35.33万
-
财政年份:1998
-
负责人:JAMES E. HIXSON
-
依托单位:
MOLECULAR GENETICS OF ATHEROSCLEROSIS
-
批准号:6242108
-
项目类别:
-
资助金额:$29.98万
-
财政年份:1997
-
负责人:JAMES E. HIXSON
-
依托单位:
PATHOBIOLOGICAL DETERMINANTS OF ATHEROSCLEROSIS IN YOUTH
-
批准号:2445162
-
项目类别:
-
资助金额:$20.96万
-
财政年份:1988
-
负责人:JAMES E. HIXSON
-
依托单位:
PATHOBIOLOGICAL DETERMINANTS OF ATHEROSCLEROSIS IN YOUTH
-
批准号:2219440
-
项目类别:
-
资助金额:$21.98万
-
财政年份:1988
-
负责人:JAMES E. HIXSON
-
依托单位:
PATHOBIOLOGICAL DETERMINANTS OF ATHEROSCLEROSIS IN YOUTH
-
批准号:3356877
-
项目类别:
-
资助金额:$17.54万
-
财政年份:1988
-
负责人:JAMES E. HIXSON
-
依托单位:
PATHOBIOLOGICAL DETERMINANTS OF ATHEROSCLEROSIS IN YOUTH
-
批准号:2219438
-
项目类别:
-
资助金额:$16.82万
-
财政年份:1988
-
负责人:JAMES E. HIXSON
-
依托单位:
PATHOBIOLOGICAL DETERMINANTS OF ATHEROSCLEROSIS IN YOUTH
-
批准号:3356881
-
项目类别:
-
资助金额:$13.89万
-
财政年份:1988
-
负责人:JAMES E. HIXSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: